血流储备分数指导PCI与冠状动脉旁路移植术后的生活质量比较
FAME 3试验纳入1500例三支冠状动脉病变患者,随机接受CABG或FFR指导的PCI。12个月时EQ-5D汇总指数两组无差异(差值0.001,95%CI -0.016至0.017,P=0.946),但PCI组早期改善更明显,且<65岁患者工作比例更高。
要点
- 12个月生活质量指数PCI与CABG相当。
- PCI组1个月时生活质量改善显著优于CABG。
- 12个月显著心绞痛比例两组均低且无显著差异。
核心结论
- FFR指导的PCI使用当代佐他莫司药物洗脱支架,1年生活质量与CABG相似。
- 两组显著心绞痛发生率均低且无显著差异,PCI组生活质量改善轨迹更优,<65岁患者工作状态更佳。
研究设计与样本
- FAME 3为多中心国际随机试验,纳入1500例三支冠状动脉病变患者,随机分为CABG组或FFR指导PCI组。
- 使用EQ-5D问卷在基线、1个月和12个月评估生活质量,并在相同时间点及6个月评估加拿大心血管学会心绞痛分级和工作状态。
主要发现
- 12个月EQ-5D汇总指数PCI组与CABG组差值0.001(95%CI -0.016至0.017;P=0.946)。
- 12个月内EQ-5D轨迹两组不同(P<0.001):1个月时PCI组EQ-5D高0.063(95%CI 0.047至0.079)。
- EQ视觉模拟评分轨迹类似。
- 12个月加拿大心血管学会2级或以上心绞痛比例PCI组6.2% vs CABG组3.1%(OR 2.5,95%CI 0.96-6.8)。
- <65岁患者12个月工作时比例PCI组68% vs CABG组57%(OR 3.9,95%CI 1.7-8.8)。
临床怎么用
- 对于三支冠状动脉病变患者,FFR指导PCI可作为CABG的替代选择,1年生活质量相当。
- PCI可能带来更早的生活质量改善,对<65岁希望维持工作的患者可优先考虑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous studies have shown that quality of life improves after coronary revascularization more so after coronary artery bypass grafting (CABG) than after percutaneous coronary intervention (PCI). This study aimed to evaluate the effect of fractional flow reserve guidance and current generation, zotarolimus drug-eluting stents on quality of life after PCI compared with CABG. METHODS: The FAME 3 trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) is a multicenter, international trial including 1500 patients with 3-vessel coronary artery disease who were randomly assigned to either CABG or fractional flow reserve-guided PCI. Quality of life was measured using the European Quality of Life-5 Dimensions (EQ-5D) questionnaire at baseline and 1 and 12 months. The Canadian Cardiovascular Class angina grade and working status were assessed at the same time points and at 6 months. The primary objective was to compare EQ-5D summary index at 12 months. Secondary end points included angina grade and work status. RESULTS: The EQ-5D summary index at 12 months did not differ between the PCI and CABG groups (difference, 0.001 [95% CI, -0.016 to 0.017]; P=0.946). The trajectory of EQ-5D during the 12 months differed (P<0.001) between PCI and CABG: at 1 month, EQ-5D was 0.063 (95% CI, 0.047 to 0.079) higher in the PCI group. A similar trajectory was found for the EQ (EuroQol) visual analogue scale. The proportion of patients with Canadian Cardiovascular Class 2 or greater angina at 12 months was 6.2% versus 3.1% (odds ratio, 2.5 [95% CI, 0.96-6.8]), respectively, in the PCI group compared with the CABG group. A greater percentage of younger patients (<65 years old) were working at 12 months in the PCI group compared with the CABG group (68% versus 57%; odds ratio, 3.9 [95% CI, 1.7-8.8]). CONCLUSIONS: In the FAME 3 trial, quality of life after fractional flow reserve-guided PCI with current generation drug-eluting stents compared with CABG was similar at 1 year. The rate of significant angina was low in both groups and not significantly different. The trajectory of improvement in quality of life was significantly better after PCI, as was working status in those <65 years old. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT02100722.
引用
- Fearon WF, Zimmermann FM, Ding VY, et al. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery. Circulation. 2022. PMID: 35369704. doi:10.1161/CIRCULATIONAHA.122.060049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。